| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Gilead Sciences, Inc. (GILD) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. GILD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 626.3K | $79.13M | -15,000 | |
| Other | 46.9K | $5.93M | - | |
| Other | 46.6K | $5.89M | - | |
| VP | 44.2K | $5.58M | - | |
| Other | 27.9K | $3.52M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 28, 2019 | Pletcher Brett A | EVP, Gen Counsel &Corp Sec | Sell | 5,677 | $63.31 | $359,412.01 | -20.9% | |
| Aug 28, 2019 | Wold Olsen Per | Director | Sale+OE | 4,908 | $63.91 | $313,670.77 | -4.8% | |
| Aug 19, 2019 | Pletcher Brett A | EVP, Gen Counsel &Corp Sec | Sell | 608 | $64.35 | $39,123.46 | -2.2% | |
| Jul 23, 2019 | Pletcher Brett A | EVP, Gen Counsel &Corp Sec | Sale+OE | 7,200 | $65.07 | $468,504.00 | -20.9% | |
| Jun 18, 2019 | Pletcher Brett A | EVP, Gen Counsel &Corp Sec | Sell | 5,816 | $68.75 | $399,850.00 | -17.6% | |
| May 1, 2019 | Cogan John Francis | Director | Sale+OE | 2,868 | $64.89 | $186,115.71 | -5.0% | |
| May 1, 2019 | Whitley Richard James | Director | Sale+OE | 9,534 | $65.02 | $619,934.05 | -27.5% | |
| Apr 24, 2019 | Cogan John Francis | Director | Sale+OE | 2,700 | $62.61 | $169,054.02 | -4.7% | |
| Apr 17, 2019 | Cogan John Francis | Director | Sale+OE | 2,700 | $64.23 | $173,423.70 | -2.4% | |
| Apr 10, 2019 | Cogan John Francis | Director | Sale+OE | 2,700 | $67.23 | $181,521.00 | -4.7% |